In silico drug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell carcinoma) treatment.

Autor: Sharif Siam MK; Department of Pharmacy, BRAC University, Dhaka, Bangladesh., Sarker A; Department of Pharmacy, BRAC University, Dhaka, Bangladesh., Sayeem MMS; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Publikováno v: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2021 Oct; Vol. 39 (17), pp. 6467-6479. Date of Electronic Publication: 2020 Aug 04.